Shanghai Haoyuan Chemexpress Co. Ltd. A (688131.SS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE1000051J4
Price
80.14 CNY
Market cap
16.83 bn CNY
P/E (2025)
–
P/S (2025)
5.87
Dividend yield
0.30 %
Net margin
8.64 %
Return on equity (ROE)
–
Return on assets (ROA)
3.94 %
Shanghai Haoyuan Chemexpress Co. Ltd. A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.27 bn CNY | 2.87 bn CNY |
| Gross profit | 959.67 m CNY | 2.87 bn CNY |
| Operating income | 236.82 m CNY | 310.12 m CNY |
| EBIT | 287.94 m CNY | 289.29 m CNY |
| Net income | 201.59 m CNY | 247.77 m CNY |
| Diluted EPS – continuing operations | 0.96 CNY | – |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
More stocks
- China Resources Double-Crane Pharmaceutical Co Ltd (600062.SS)
- StoneCo Ltd (STNE)
- Cyfrowy Polsat SA (CPS.WA)
- Guizhou Chanhen Chemical Corp (002895.SZ)
- CMC Markets PLC (CMCX.L)
- Jenoptik (JEN.DE)
- AIMA Technology Group Co Ltd (603529.SS)
- Weifu High-Technology Group Co Ltd (000581.SZ)
- FIRST BUSEY CORP /NV/ (BUSE)
- Allos S.A. (ALOS3.SA)
- StarPower Semiconductor Ltd (603290.SS)
- Ruentex Development Co Ltd (9945.TW)
Not investment advice. All data without warranty, price as of 27.10.2026. Details in the risk notice.